EASD 2016
Altering the course of type 1 diabetes
Mohammad Alhadj Ali
Dr. Mohammad Alhadj Ali
Proinsulin peptide immunotherapy in new-onset type 1 diabetes is well-tolerated and associated with reduced daily insulin usage || Oral Presentation #108

To view this page ensure that Adobe Flash Player version 10.2.0 or greater is installed.

Get Adobe Flash player
There are no comments yet. Be the first one to post a comment.
Related To This Webcast